1 not yet recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
Follow PF06821497: new trials by email Literature Review of PF06821497 trials Research Report on PF06821497
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Mevrometostat With Enzalutamide in People With Prostate Cancer Who Have Previously Received Androgen Receptor Pathway Inhibitor Therapy Mevrometostat, Enzalutamide - Metastatic Castrate Resistant Prostate Cancer (mCRPC), Prostate Cancer (Adenocarcinoma) | Phase 2 | Not yet recruiting | Prostate Cancer Clinical Trials Consortium | 60 | 2026-08-01 | 2026-05-18 |
Adenocarcinoma (1) · Prostatic Neoplasms (1)
Prostate Cancer Clinical Trials Consortium (1)